Go to content
UR Home

Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients

DOI to cite this document:
Friebus‐Kardash, Justa ; Eisenberger, Ute ; Ackermann, Jessica ; Kribben, Andreas ; Witzke, Oliver ; Wenzel, Jürgen J. ; Rohn, Hana ; Fiedler, Melanie
[img]PDF - Published Version
(825kB) - Repository staff only
Date of publication of this fulltext: 01 Oct 2020 07:06


BACKGROUND: Hepatitis E virus (HEV) genotype 3 infection frequently progresses to chronic disease with persisting HEV viremia in immunocompromised patients. Here, we evaluated the prevalence of HEV infection in renal allograft recipients and investigated the efficacy and tolerability of ribavirin monotherapy. METHODS: A total of 947 recipients on average 8.7 years post transplant were screened ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons